Raleigh Capital Management Inc.

Position in SNY — Sanofi

CIK 1911726 CARY, NC

Position in SNY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,704,388

-$30,790 QoQ

Shares Held

63,394

+11.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.35%

of 13F equity value

Holder Rank

#160

of 712 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Raleigh Capital Management Inc. holds $16,702,583 across 11 Drug Manufacturers - General names. SNY ranks #3 (16.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	18,091	$4,552,419
2	PFE	Pfizer Inc	114,644	$2,760,627
3	SNY	Sanofi This page	63,394	$2,704,388
4	LLY	ELI LILLY & Co	1,690	$2,027,036
5	MRK	Merck & Co., Inc.	15,000	$1,927,500
6	AMGN	Amgen Inc	4,020	$1,455,722
7	JNJ	Johnson & Johnson	3,730	$947,308
8	GILD	Gilead Sciences, Inc.	2,017	$254,827

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,704,388	63,394	+11.7%	Shares	Sole	2026-07-21
2026-03-31	$2,735,178	56,770	+33.4%	Shares	Sole	2026-04-28
2025-12-31	$2,062,360	42,558	+4.0%	Shares	Sole	2026-01-21
2025-09-30	$1,931,188	40,915	+3.9%	Shares	Sole	2025-11-04
2025-06-30	$1,902,447	39,380	+2.8%	Shares	Sole	2025-07-17
2025-03-31	$2,124,062	38,299	+18.1%	Shares	Sole	2025-04-29
2024-12-31	$1,564,340	32,435	-1.2%	Shares	Sole	2025-01-17
2024-09-30	$1,892,626	32,841	-1.7%	Shares	Sole	2024-10-21
2024-06-30	$1,620,519	33,399	+24.1%	Shares	Sole	2024-07-31
2024-03-31	$1,307,728	26,908	+31.0%	Shares	Sole	2024-05-13
2023-12-31	$1,021,751	20,546	-25.3%	Shares	Sole	2024-02-21
2023-09-30	$1,474,724	27,493	-0.3%	Shares	Sole	2023-12-08
2023-06-30	$1,485,807	27,566	+18.3%	Shares	Sole	2023-07-25
2023-03-31	$1,268,094	23,302	+72718.8%	Shares	Sole	2023-05-22
2021-12-31	$1,603	32	—	Shares	Sole	2022-02-16
No filing history on record for this holder in this stock.